Profile
Full Name
Royalty Pharma plcTicker Symbol
RPRXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 16, 2020Indexes
Not includedWebsite
http://www.royaltypharma.comEmployees
75Key Details
Price
$35.88(-0.42%)
Market cap
$15.12B(Large cap)
Last Dividend
$0.22
TTM Dividend yield
2.40%
Annual revenue
$2.26B(-3.86% YoY)
Annual EPS
$1.91(-24.51% YoY)
PE ratio
15.31
Next earnings date
Aug 6, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Events
Dividend per share
Dividend yield
Other
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Oct 25, 24 Citigroup
BuyAug 14, 24 Goldman Sachs
BuyJul 11, 24 Morgan Stanley
OverweightJun 3, 24 UBS
NeutralApr 12, 24 B of A Securities
BuyFeb 20, 24 JP Morgan
OverweightFeb 20, 24 Goldman Sachs
BuyNov 9, 23 Morgan Stanley
OverweightOct 11, 23 Morgan Stanley
OverweightAug 9, 23 Morgan Stanley
OverweightInstitutional Ownership
- What is the ticker symbol for Royalty Pharma?
- Does Royalty Pharma pay dividends?
- What sector is Royalty Pharma in?
- What industry is Royalty Pharma in?
- What country is Royalty Pharma based in?
- When did Royalty Pharma go public?
- Is Royalty Pharma in the S&P 500?
- Is Royalty Pharma in the NASDAQ 100?
- Is Royalty Pharma in the Dow Jones?
- When was Royalty Pharma's last earnings report?
- When does Royalty Pharma report earnings?
- Should I buy Royalty Pharma stock now?
What is the ticker symbol for Royalty Pharma?
The ticker symbol for Royalty Pharma is NASDAQ:RPRX
Does Royalty Pharma pay dividends?
Yes, Royalty Pharma pays dividends. The last payment was $0.22, with an ex-dividend date on May 16, 2025
What sector is Royalty Pharma in?
Royalty Pharma is in the Healthcare sector
What industry is Royalty Pharma in?
Royalty Pharma is in the Biotechnology industry
What country is Royalty Pharma based in?
Royalty Pharma is headquartered in United States
When did Royalty Pharma go public?
Royalty Pharma's initial public offering (IPO) was on June 16, 2020
Is Royalty Pharma in the S&P 500?
No, Royalty Pharma is not included in the S&P 500 index
Is Royalty Pharma in the NASDAQ 100?
No, Royalty Pharma is not included in the NASDAQ 100 index
Is Royalty Pharma in the Dow Jones?
No, Royalty Pharma is not included in the Dow Jones index
When was Royalty Pharma's last earnings report?
Royalty Pharma's most recent earnings report was on May 8, 2025
When does Royalty Pharma report earnings?
The next expected earnings date for Royalty Pharma is Aug 6, 2025
Should I buy Royalty Pharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions